Urteste S.A. (WSE:URT)
Poland · Delayed Price · Currency is PLN 45.00
+1.00 (2.27%)
Jun 12, 2026, 4:14 PM CET
Urteste Revenue
In the year 2025, Urteste had annual revenue of 2.50M PLN with 39.11% growth. Urteste had revenue of 711.00K in the quarter ending March 31, 2026, a decrease of -1.25%.
Revenue
2.50M
Revenue Growth
+39.11%
P/S Ratio
27.43
Revenue / Employee
69.56K
Employees
38
Market Cap
68.67M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.50M | 704.00K | 39.11% |
| Dec 31, 2024 | 1.80M | 470.00K | 35.34% |
| Dec 31, 2023 | 1.33M | 1.33M | 44,233.33% |
| Dec 31, 2022 | 3.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BIOTON | 266.02M |
| Ryvu Therapeutics | 88.38M |
| Synthaverse | 42.19M |
| Mabion | 17.61M |
| Molecure | 6.52M |
| Pharmena | 1.61M |
| Poltreg | 250.00K |
| NanoGroup | 8.00K |